Tag: Teleflex

QT Vascular Enters Into Asset Purchase And Option Agreement With Teleflex

SINGAPORE, May 24, 2018 /PRNewswire/ — QT Vascular Ltd., (“QT Vascular“, and with its subsidiaries, the “Company“), announced today that it has entered into an asset purchase and option agreement (the “APOA“) with Teleflex Life Sciences Unlimited Company and Teleflex Incorporated (“Teleflex“). Under the APOA, Teleflex will acquire the non-drug coated product line […]

Teleflex to Introduce the New TrapLiner® Catheter in Europe and Showcase the Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump (IABP) at the European Association for Percutaneous Cardiovascular Interventions Course (EuroPCR) 2018

WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, coronary and peripheral interventions, will showcase its complex PCI product portfolio and the Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump (IABP) at the EuroPCR being held in Paris, France on May 22 – […]

Medtronic Expands Focus on Interventional Oncology with Its U.S. Launch of OptiSphere(TM) Embolization Spheres

DUBLIN – April 17, 2018 – Medtronic plc (NYSE: MDT) today announced its U.S. launch of OptiSphere(TM) embolization spheres, a resorbable embolic platform designed for embolization of hypervascular tumors. OptiSphere offers patients an alternative treatment option, a resorbable embolic, with comparable results to a permanent embolic.1 Hypervascular tumors can present as […]

Teleflex Announces U.S. Launch of Two Next-Generation Versions of Its 0.035” Snares for Peripheral Procedures

Expro Elite™ Snare features a helical loop and Sympro Elite™ Snare features a simple 90-degree loop – both devices are available in five loop diameters for clinical versatility in retrieving or repositioning intravascular devices – preassembled, one-piece design allows rapid deployment through any 0.035” compatible lumen. WAYNE, Pa.–(BUSINESS WIRE)– Teleflex Incorporated (NYSE: […]

Teleflex Surpasses 200,000 Successfully Reprocessed ClosureFast® Catheters

WAYNE, Pa.–(BUSINESS WIRE)– Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that more than 200,000 ClosureFast® Catheters have been successfully reprocessed by the company’s partner, Northeast Scientific, Inc. (NES), since NES received FDA clearance for reprocessing the popular vein ablation catheter in 2011. […]

Teleflex Inc. (TFX) To Present The Peripheral Intervention Product Portfolio From Its New Subsidiary, Vascular Solutions At The Annual Meeting And Postgraduate Course Of The Cardiovascular And Interventional Radiological Society Of Europe (CIRSE) 2017

WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, will showcase the product portfolio recently acquired from its new subsidiary, Vascular Solutions, as well as its Arrow® Hemodialysis, Oncology and Peripheral Intervention Solutions at the CIRSE Congress being held in […]